Prevalence of Neutralizing Antibodies against Adenoviruses types -C5, -D26 and -B35 used in vaccination platforms, in Healthy and HIV-Infected Adults and Children from Burkina Faso and Chad
Published in 2022 by
Aline Raissa Ouoba,
Océane Paris,
Chatté Adawaye,
Guy Takoudjou Dzomo,
Abderrazzack Adoum Fouda,
Dramane Kania,
Amidou Diarra,
Zenaba Abdramane Kallo,
Isidore Tiandiogo Traore,
Sodiomon Bienvenu Sirima 
,
Edouard Tuaillon,
Philippe Van de Perre,
Eric J. Kremer,
Franck Jean Daniel Mennechet
,
Edouard Tuaillon,
Philippe Van de Perre,
Eric J. Kremer,
Franck Jean Daniel Mennechet
